• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Clarity receives second ophthalmic patent

Article

Clarity Medical Systems Inc.’s compact wavefront sensor module has received a patent from the U.S. Patent and Trademark Office.

 

Pleasanton, CA-Clarity Medical Systems Inc.’s compact wavefront sensor module has received a patent from the U.S. Patent and Trademark Office.

The patent is the continuation of Clarity’s expanding HOLOS technology. It includes the attachment of the compact HOLOS wavefront sensor onto a surgical microscope or slit lamp, or the integration into a surgical microscope or slit lamp.

Clarity’s first product application of the technology will be for refractive cataract surgery with HOLOS IntraOp-an intraoperative module that attaches to any standard surgical microscope to assist surgeons in monitoring and confirming the accurate refractive status of a patient’s eye throughout all phases of the surgical procedure.

“The compact size of (the technology) will help ophthalmologists rapidly and efficiently measure their patient’s refractive state during cataract surgery, as well as provide real-time surgical guidance while preserving key surgeon ergonomics,” said Keith Mullowney, president and chief executive officer of Clarity.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Related Videos
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Elias Kahan, MD, speaks at the 2024 ARVO meeting
Andrew Pucker, OD, PhD
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
© 2024 MJH Life Sciences

All rights reserved.